InvestSMART

Atlas Arteria (ASX:ALX)

ALERT: Price-sensitive ASX Announcement for ALX
Current share price for ALX : $5.080 -0.09 (-1.74%)+
Announcement
Release
18 Jul 2025 8:28AM
Price at Release
$5.170
Full Release
download
Summary
Atlas Arteria announced that the Virginia Supreme Court has affirmed the State Corporation Commission's decision to deny the toll rate application by Toll Road Investors Partnership II for the Dulles Greenway. This decision allows TRIP II's federal case to proceed, which alleges constitutional violations and seeks various forms of relief. TRIP II is working with the SCC working group and plans to submit a new rate application. Atlas Arteria is involved in toll road businesses in France, Germany, and the United States, focusing on sustainable management and stakeholder value.
Key Points
  • Virginia Supreme Court affirmed SCC's decision denying TRIP II's toll rate application.
  • TRIP II's federal case will proceed, alleging constitutional violations.
  • TRIP II plans to submit a new rate application.
  • Atlas Arteria operates toll roads in France, Germany, and the United States.
  • The company focuses on sustainable management and stakeholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.